Juvéderm vs Restylane: HA Filler Families Compared by Crosslinking, Indication, and Longevity

Juvéderm fillers (Allergan Aesthetics) use Vycross technology, a proprietary crosslinking method that combines low- and high-molecular-weight HA with biphasic crosslinking. This creates a more cohesive gel with higher viscosity and pseudoplasticity—meaning it flows smoothly under injection pressure but holds its shape once placed. Vycross fillers tend to have a firmer feel and integrate more slowly into surrounding tissue.

Restylane fillers (Galderma) use NASHA (Non-Animal Stabilized Hyaluronic Acid) technology, which employs monophasic crosslinking of a single HA molecular weight. This produces a more granular particle structure with lower viscosity and faster tissue integration. Restylane gels feel softer on palpation and blend more readily into the dermis.

The practical implication: Juvéderm suits sculpting and adding volume to defined areas (lips, cheeks, chin); Restylane excels at smoothing fine lines and blending into superficial rhytides. Neither is "better"—they solve different problems.

Product Lineup and Indications

Juvéderm Ultra family (0.24% HA, 24 mg/mL):

• Ultra: superficial lines, lip enhancement
• Ultra Plus: moderate folds, lip augmentation
• Ultra XC: same formulations with lidocaine

Juvéderm Voluma XC (20 mg/mL, higher G' modulus):

• Deep cheek and midface volumization
• Jawline definition
• FDA-cleared for up to 2 years

Restylane family (0.2% HA, 20 mg/mL):

• Restylane: fine lines, superficial folds
• Restylane Lyft: midface volume, cheek augmentation
• Restylane Defyne: moderate-to-deep folds with dynamic support
• Restylane Refyne: dynamic expression lines (nasolabial folds, marionette lines)

Restylane Lyft carries FDA clearance for up to 1 year; Refyne and Defyne are labeled for 6 months, though clinical experience often extends to 9–12 months.

Longevity and Clinical Durability

Juvéderm Ultra products typically last 6–9 months in most patients; Voluma, with its higher crosslink density, reaches 12–24 months. The firmer gel and slower resorption profile mean less frequent touch-ups but also a higher risk of overfill or visible nodules if placed too superficially.

Restylane products average 6–12 months depending on the line and patient metabolism. The softer integration means a more natural appearance early on but faster fade in high-mobility zones (lips, perioral). Many injectors use Restylane for initial treatment and Juvéderm for maintenance, banking on Juvéderm's longevity to reduce patient visit frequency.

Individual variation is significant: thin-skinned patients, high metabolizers, and those with active lifestyles see faster resorption across both families. Smoking and sun exposure accelerate breakdown.

Economics and Rebate Structures

Both families are available through Allergan's Alle and Galderma's Aspire loyalty programs. Juvéderm syringes typically cost practices $8–$12 per mL wholesale (depending on volume tier and rebate); Restylane runs $7–$11 per mL. Voluma commands a premium ($12–$15) due to its longevity claim and higher G' modulus.

Your margin depends on patient pricing and treatment volume. A practice charging $12–$15 per syringe of Restylane Refyne (1 mL) at $8 cost yields 33–47% gross margin; the same syringe of Voluma at $14 cost and $20 patient price yields 30% margin but justifies fewer appointments annually per patient.

Clinical Considerations

Mixing families in the same treatment area is common but requires understanding their different integration rates. Placing Restylane over Juvéderm risks visible layering; the reverse (Juvéderm over Restylane) blends more smoothly because Juvéderm's firmness masks the softer base.

Vascular compromise, bruising, and Tyndall effect occur with both, but Restylane's finer particle structure makes it slightly more prone to superficial Tyndall if placed too high in thin-skinned patients. Juvéderm's cohesiveness can occasionally create palpable nodules if overfilled or placed in high-mobility zones.

Both families are non-permanent, reversible with hyaluronidase, and carry similar safety profiles when injected by trained providers. The choice between them hinges on your injection philosophy, patient expectations around touch-up frequency, and the specific anatomic problem you're solving.

Verify current pricing, rebate terms, and FDA indications with Allergan Aesthetics and Galderma directly, as these shift with volume commitments and promotional cycles.